COPD exacerbations · 5: Management

Rodríguez-Roisin, R.
June 2006
Thorax;Jun2006, Vol. 61 Issue 6, p535
Academic Journal
The article presents a review of the most crucial evidence based therapeutic options for the management of exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Exacerbations of COPD have the characteristics of enhanced airway inflammation and oedema and systemic inflammation, leading to an airflow limitation and gas exchange defects. The antibiotics, bronchodilators, and corticosteroids are 3 classes of drugs that are used for exacerbations of COPD. Non-pharmacological treatment are also discussed.


Related Articles

  • Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. Black, Peter N.; Morgan-Day, Althea; McMillan, Tracey E.; Poole, Phillippa J.; Young, Robert P. // BMC Pulmonary Medicine;2004, Vol. 4, p13 

    Background: Prophylactic treatment with N-acetylcysteine (NAC) for 3 months or more is associated with a reduction in the frequency of exacerbations of chronic obstructive pulmonary disease (COPD). This raises the question of whether treatment with NAC during an acute exacerbation will hasten...

  • Management of COPD Exacerbations. EVENSEN, ANN E. // American Family Physician;3/1/2010, Vol. 81 Issue 5, p607 

    Exacerbations of chronic obstructive pulmonary disease contribute to the high mortality rate associated with the disease. Randomized controlled trials have demonstrated the effectiveness of multiple interventions. The first step in outpatient management should be to increase the dosage of...

  • Managing severe COPD with frequent exacerbations. Booker, Rachel // Practice Nurse;2/26/2010, Vol. 39 Issue 4, p13 

    The article focuses on the management of patients with chronic obstructive pulmonary disease (COPD) who have frequent exacerbations and severe disease. An overview of the disease is provided including the impact of an acute exacerbation of COPD (AECOPD). Management of AECOPD is presented in...

  • Asthma biology.  // Thorax;Dec2003 Supplement 3, Vol. 58, piii60 

    Fixed airflow obstruction occurs in a minority of patients with asthma and is associated with increased morbidity and mortality. To identify potential risk factors for the development of fixed airflow obstruction, researchers have investigated the association between post bronchodilator FEV and...

  • COPD management. Newson, Louise // GP: General Practitioner;7/7/2006, p36 

    The article presents information on the management of COPD. COPD is the fourth leading cause of death all over the world. It causes over 30,000 deaths a year in Great Britain. These days there are many treatment options available for patients with COPD. Physicians are increasingly prescribing...

  • Inhaled corticosteroids are first-line control for asthma. Zablocki, Elaine // Managed Healthcare Executive;Jul2009, Vol. 19 Issue 7, p19 

    The article presents a study which evaluates the effectiveness of inhaled corticosteroids in managing asthma. Result of a study shows that asthmatic patients who spend time with a healthcare professional developing a personalized self- management plan will improved medication compliance and...

  • The Respiratory Anguish of Heaves. Kitchener, Nicole // Horse-Canada.com;Jul/Aug2012, Vol. 11 Issue 4, p14 

    The article features the equine respiratory condition called heaves, also known as recurrent airway obstruction (RAO). Frequently compared with asthma in humans, heaves are said to be chronic, incurable and can be debilitating. To reduce airway inflammation, veterinarians often use two main drug...

  • First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis. Price, David; Miravitlles, Marc; Pavord, Ian; Thomas, Mike; Wedzicha, Jadwiga; Haughney, John; Bichel, Katsiaryna; West, Daniel // Primary Care Respiratory Society UK;11/3/2016, p16061 

    Clinical guidelines recommend long-acting bronchodilators as first maintenance therapy for chronic obstructive pulmonary disease (COPD), with inhaled corticosteroids (ICS) reserved for patients with more severe disease and exacerbations. The aim of this analysis was to examine real-life...

  • Help patients quit and optimise remaining lung function.  // New Zealand Doctor;10/28/2015, p36 

    The article discusses how to help patients quit smoking and optimise remaining lung function. Obstructive lung disease (COPD) could be prevented if an individual would stop smoking, It describes tools and methods to treat COPD including bronchodilators, theophylline, oral corticosteroids and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics